H. Laignelet - Academia.edu (original) (raw)

Papers by H. Laignelet

Research paper thumbnail of CO127 Atopic March and Comorbidities in Patients with Atopic Dermatitis in Colombia

Research paper thumbnail of Influence de la nutrition artificielle sur la morphologie de la muqueuse colique chez le rat

Research paper thumbnail of Should Partial Hydrolysates Be Used As Starter Infant Formula? A Working Group Consensus

Journal of pediatric gastroenterology and nutrition, Jan 23, 2015

Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Since prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, non-randomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. However, with ...

Research paper thumbnail of PNS53 Description of Clinical Characteristics and Self Reported Willingness to Pay for New Treatments in Colombian Patients with Psoriasis and Psoriatic Arthritis

Value in Health Regional Issues, 2019

Research paper thumbnail of POSA200 Characterization of Atopic Dermatitis Patients Treated in Colombia

Research paper thumbnail of PMS52 Epidemiology of Dermatitis Atopic in America: Systematic Review

Research paper thumbnail of Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus

Partially hydrolyzed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolyzed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Because prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, nonrandomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. With respect to long-term outcomes, particularly referring to immune, metabolic and hormonal effects, data are, however, nonexistent. From a regulatory point of view, pHFs meet the nutrient requirements to be considered as standard formula for term healthy infants. Cost, which is different from country to country, should be considered in the

Research paper thumbnail of Should Partial Hydrolysates Be Used As Starter Infant Formula? A Working Group Consensus

Journal of pediatric gastroenterology and nutrition, Jan 23, 2015

Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Since prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, non-randomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. However, with ...

Research paper thumbnail of CO127 Atopic March and Comorbidities in Patients with Atopic Dermatitis in Colombia

Research paper thumbnail of Influence de la nutrition artificielle sur la morphologie de la muqueuse colique chez le rat

Research paper thumbnail of Should Partial Hydrolysates Be Used As Starter Infant Formula? A Working Group Consensus

Journal of pediatric gastroenterology and nutrition, Jan 23, 2015

Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Since prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, non-randomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. However, with ...

Research paper thumbnail of PNS53 Description of Clinical Characteristics and Self Reported Willingness to Pay for New Treatments in Colombian Patients with Psoriasis and Psoriatic Arthritis

Value in Health Regional Issues, 2019

Research paper thumbnail of POSA200 Characterization of Atopic Dermatitis Patients Treated in Colombia

Research paper thumbnail of PMS52 Epidemiology of Dermatitis Atopic in America: Systematic Review

Research paper thumbnail of Should Partial Hydrolysates Be Used as Starter Infant Formula? A Working Group Consensus

Partially hydrolyzed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolyzed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Because prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, nonrandomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. With respect to long-term outcomes, particularly referring to immune, metabolic and hormonal effects, data are, however, nonexistent. From a regulatory point of view, pHFs meet the nutrient requirements to be considered as standard formula for term healthy infants. Cost, which is different from country to country, should be considered in the

Research paper thumbnail of Should Partial Hydrolysates Be Used As Starter Infant Formula? A Working Group Consensus

Journal of pediatric gastroenterology and nutrition, Jan 23, 2015

Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of a... more Partially hydrolysed formulas (pHFs) are increasingly used worldwide, both in the prevention of atopic disease in at-risk infants and in the therapeutic management of infants with functional gastrointestinal manifestations. Since prevention is always preferable to treatment, we reviewed the literature aiming to find an answer for the question whether pHF may be recommended for feeding all infants if breast-feeding is not possible. PubMed and Cochrane databases were searched up to December 2014. In addition, to search for data that remained undetected by the searches, we approached authors of relevant articles and major producers of pHFs asking for unpublished data. Because few data were found, non-randomized, controlled trials and trials in preterm infants were included as well. Overall, only limited data could be found on the efficacy and safety of pHF in healthy term infants. Available data do not indicate that pHFs are potentially harmful for healthy, term infants. However, with ...